179 related articles for article (PubMed ID: 1967770)
1. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease.
Schutzer SE; Coyle PK; Belman AL; Golightly MG; Drulle J
Lancet; 1990 Feb; 335(8685):312-5. PubMed ID: 1967770
[TBL] [Abstract][Full Text] [Related]
2. Borrelia burgdorferi-specific immune complexes in acute Lyme disease.
Schutzer SE; Coyle PK; Reid P; Holland B
JAMA; 1999 Nov; 282(20):1942-6. PubMed ID: 10580460
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and -nonspecific complexes.
Coyle PK; Schutzer SE; Belman AL; Krupp LB; Golightly MG
Ann Neurol; 1990 Dec; 28(6):739-44. PubMed ID: 2285261
[TBL] [Abstract][Full Text] [Related]
4. New method for detection of Borrelia burgdorferi antigen complexed to antibody in seronegative Lyme disease.
Brunner M
J Immunol Methods; 2001 Mar; 249(1-2):185-90. PubMed ID: 11226475
[TBL] [Abstract][Full Text] [Related]
5. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
6. Detection and preliminary characterization of circulating immune complexes in patients with Lyme disease.
Zhong W; Oschmann P; Wellensiek HJ
Med Microbiol Immunol; 1997 Oct; 186(2-3):153-8. PubMed ID: 9403844
[TBL] [Abstract][Full Text] [Related]
7. Lyme arthritis: oligoclonal anti-Borrelia burgdorferi IgG antibodies occur in joint fluid and serum.
Cruz M; Hansen K; Ernerudh J; Steere AC; Link H
Scand J Immunol; 1991 Jan; 33(1):61-71. PubMed ID: 1996408
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity to Borrelia burgdorferi proteins in serum samples from residents of a tropical country nonendemic for Lyme disease.
Burkot TR; Schriefer ME; Larsen SA
J Infect Dis; 1997 Feb; 175(2):466-9. PubMed ID: 9203675
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis.
Dressler F; Ackermann R; Steere AC
J Infect Dis; 1994 Feb; 169(2):313-8. PubMed ID: 8106763
[TBL] [Abstract][Full Text] [Related]
10. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.
Dattwyler RJ; Volkman DJ; Luft BJ; Halperin JJ; Thomas J; Golightly MG
N Engl J Med; 1988 Dec; 319(22):1441-6. PubMed ID: 3054554
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis.
Zbinden R; Goldenberger D; Lucchini GM; Altwegg M
J Clin Microbiol; 1994 Jul; 32(7):1795-8. PubMed ID: 7929776
[TBL] [Abstract][Full Text] [Related]
12. Three-year study of antibody to Borrelia burgdorferi in southern Spain.
Gutierrez J; Maroto MC; De la Higuera A; Guerrero M; Padilla E; Piédrola G
Eur J Clin Microbiol Infect Dis; 1995 Jun; 14(6):542-6. PubMed ID: 7588832
[TBL] [Abstract][Full Text] [Related]
13. T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation.
Krause A; Brade V; Schoerner C; Solbach W; Kalden JR; Burmester GR
Arthritis Rheum; 1991 Apr; 34(4):393-402. PubMed ID: 2012626
[TBL] [Abstract][Full Text] [Related]
14. Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens.
Fawcett PT; Gibney KM; Rose CD; Dubbs SB; Doughty RA
J Rheumatol; 1992 Apr; 19(4):582-7. PubMed ID: 1593581
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin M capture assay for serologic confirmation of early Lyme disease: analysis of immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitope.
Brunner M; Stein S; Mitchell PD; Sigal LH
J Clin Microbiol; 1998 Apr; 36(4):1074-80. PubMed ID: 9542940
[TBL] [Abstract][Full Text] [Related]
16. Lyme disease in clinical practice.
Płusa T; Ligezińska B; Zabielski S; Raczka A
Pneumonol Alergol Pol; 1992; 60 Suppl 1():71-5. PubMed ID: 1292852
[No Abstract] [Full Text] [Related]
17. Detection of serum antibodies against Borrelia burgdorferi with some commercially available serological tests.
Melby K; Steinbakk M; Jensenius M; Figenschau KJ
NIPH Ann; 1990 Dec; 13(2):37-44. PubMed ID: 2093855
[TBL] [Abstract][Full Text] [Related]
18. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.
Schmitz JL; Schell RF; Lovrich SD; Callister SM; Coe JE
Infect Immun; 1991 Jun; 59(6):1916-21. PubMed ID: 2037352
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
